Shanghai COVID Cases Result In More Harsh Citywide Closures
On April 16th, Shanghai reported a new high for symptomatic COVID-19 cases, while other cities throughout China tightened controls as the country continued its...
Covaxin Phase 2 And 3 Trials Have Been Paused By The USFDA
The phase 2/3 clinical trials for Bharat Biotech's COVID-19 vaccine, Covaxin, in the United States have been halted by the US Food and Drug...
The US Intends To Implement Federal Employee Vaccination Law
The Justice Department petitioned a federal appeals court on April 11 to enable the Biden administration to begin implementing a federal employee immunisation mandate that...
NICE Asks Gilead To Lower Trodelvy Rate And Bans Eczema Meds
The United Kingdom's drug price watchdog had a bad week. The National Institute of Health and Care Excellence has denied Gilead Sciences' Trodelvy for...
Major Success Factors For Clinical Development Organizations
Executive leaders at pharma and biotech companies are realising that an initial investment in a clinical trial associate's (CTA) career can impact and build...
COVID-19 Hospitalizations Reach An All-Time Low In The US
There are 16,138 people in hospitals with COVID-19 as of April 8, which is the lowest number since the US Department of Health and Human...
Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates
Pfizer Inc. and ReViral Ltd. announced that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...